Farapulse Stock

farapulse.comHealthcareFounded: 1900Funding to Date: $80.75MM

FARAPULSE provides tissue-selective PFA therapy through development and commercialization of its dedicated generator (FARASTAR), PVI-focused catheter (FARAWAVE), large-area focal catheter (FARAFLEX), precision focal catheter (FARAPOINT) and a proprietary deflectable delivery sheath (FARADRIVE).

Register for Details

For more details on financing and valuation for Farapulse, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Farapulse.

Register Today

Team

Management Team

Allan Zingeler
President, Board Member & Chief Executive Officer

Board Members

James Eadie MD
Santé Ventures
Robert Weisskoff Ph.D
F-Prime Capital Partners
Andrew ElBardissi MD
Deerfield Management
Chris Kaster

Other companies like Farapulse in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector